From TokenPost · · 40s
TL;DR: Jaguar Health Targets Mid-2027 MVID Filing
Jaguar Health aims for mid-2027 drug submission after $10m debt cut.
Jaguar Health plans mid-2027 new drug application for pediatric MVID treatment after reducing debt by over $10 million. Jaguar Health aims for mid-2027 drug submission after $10m debt cut. Jaguar Health plans mid-2027 new drug application for crofelemer to treat pediatric MVID after completing pivotal-trial enrollment.
- Jaguar Health Targets MVID Filing
- Debt Reduction Milestone
- Next Milestone
Read the story version — the same reporting as a swipeable deck of 3 cards.






